EMERGEX VACCINES LIMITED

Dissolved Abingdon

Research and experimental development on biotechnology

0 employees website.com
Research and experimental development on biotechnology
E

EMERGEX VACCINES LIMITED

Research and experimental development on biotechnology

Founded 30 Jan 2020 Dissolved Abingdon, United Kingdom 0 employees website.com
Research and experimental development on biotechnology
Accounts Submitted 2 Aug 2023
Confirmation Submitted 1 Mar 2024 Next due 12 Feb 2025 17 months overdue
Net assets £1 £0 2022 year on year
Total assets £1 £0 2022 year on year
Total Liabilities £0
Charges None No charges registered

Contact & Details

Contact

Registered Address

4&5 Dunmore Court Wootton Road Abingdon Oxfordshire OX13 6BH United Kingdom

Full company profile for EMERGEX VACCINES LIMITED (12434233), a dissolved company based in Abingdon, United Kingdom. Incorporated 30 Jan 2020. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Apr → 31 Mar 2023
Type dormant
Next accounts
Due by

Net Assets, Total Assets & Total Liabilities (2020–2022)

Cash in Bank

N/A

Net Assets

£1.00

Total Liabilities

N/A

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Financial History

Revenue, profit, EBITDA and key financial figures

2023
31 Mar Year End
2022
31 Mar Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

2 active
Status
Storme Jo-anne Moore-thornicroftDirectorBritishEngland5230 Jan 2020Active
Thomas William RademacherDirectorBritishUnited Kingdom7630 Jan 2020Active

Shareholders

Shareholders (1)

Gylden Pharma Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Active
Notified 30 Jan 2020
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

GYLDEN PHARMA LIMITED united kingdom
EMERGEX VACCINES LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
28 Jan 2025GazetteGazette Dissolved Voluntary
12 Nov 2024GazetteGazette Notice Voluntary
5 Nov 2024DissolutionDissolution Application Strike Off Company
1 Mar 2024Confirmation StatementConfirmation statement made on 29 Jan 2024 with no updates
2 Aug 2023AccountsAnnual accounts made up to 31 Mar 2023
28 Jan 2025 Gazette

Gazette Dissolved Voluntary

12 Nov 2024 Gazette

Gazette Notice Voluntary

5 Nov 2024 Dissolution

Dissolution Application Strike Off Company

1 Mar 2024 Confirmation Statement

Confirmation statement made on 29 Jan 2024 with no updates

2 Aug 2023 Accounts

Annual accounts made up to 31 Mar 2023

Recent Activity

Latest Activity

Gazette Dissolved Voluntary

1 years ago on 28 Jan 2025

Gazette Notice Voluntary

1 years ago on 12 Nov 2024

Dissolution Application Strike Off Company

1 years ago on 5 Nov 2024

Confirmation statement made on 29 Jan 2024 with no updates

2 years ago on 1 Mar 2024

Annual accounts made up to 31 Mar 2023

2 years ago on 2 Aug 2023